Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy

@inproceedings{Marrosu2017GapmerAO,
  title={Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy},
  author={Elena Marrosu and Pierpaolo Ala and Francesco Muntoni and Haiyan Zhou},
  booktitle={Molecular therapy. Nucleic acids},
  year={2017}
}
Dominant-negative mutations in the genes that encode the three major α chains of collagen type VI, COL6A1, COL6A2, and COL6A3, account for more than 50% of Ullrich congenital muscular dystrophy patients and nearly all Bethlem myopathy patients. Gapmer antisense oligonucleotides (AONs) are usually used for gene silencing by stimulating RNA cleavage through the recruitment of an endogenous endonuclease known as RNase H to cleave the RNA strand of a DNA-RNA duplex. In this study, we exploited the… CONTINUE READING
BETA
2
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 50 REFERENCES

The collagen VI-related myopathies: muscle meets its matrix

  • Nature Reviews Neurology
  • 2011
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL